In this article, Dr Malcolm Haddrick (Medicines Discovery Catapult) and Professor Steve Evans (University of Leeds) highlight the exciting and innovative new method of drug delivery — microbubbles.
bubbles
A current challenge across the pharmaceutical industry is how to improve the rate of attrition in the delivery of new medicines to patients.1Innovative drug delivery technologies have the potential to address this challenge by overcoming the cell permeability limitations of promising novel therapeutics (e.g., PROTACs) or by ‘rescuing’ existing drugs with poor solubility or those with a low therapeutic index. Investment in therapeutic delivery platforms has the potential to be broadly impactful across multiple drug modalities that can be applied to a wide range of disease areas.